Clinical Trials
4 trialsNCT05683834 2026-04-22
Trial Evaluating the Immunogenicity and Safety of an Adjuvanted Epstein-Barr Virus (EBV) Glycoprotein 350 Vaccine in EBV-seronegative Persons
National Institutes of Health Clinical Center (CC)
Phase 1/2 Completed
NCT07256431 2025-12-01
RIS - EBVD
Centre Hospitalier Universitaire de NÄ«mes
Completed
NCT04189835 2025-11-20
EVITA
University of Aarhus
Completed
NCT00001379 2025-06-19
Treatment and Natural History Study of Lymphomatoid Granulomatosis
National Institutes of Health Clinical Center (CC)
Phase 2 Completed